Director/PDMR Shareholding

By

Regulatory News | 30 May, 2019

Updated : 13:03

RNS Number : 6385A
UDG Healthcare Public Limited Co.
30 May 2019
 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 These forms are required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

Peter Chambre

 

 

2

Reason for the notification

 

a)

Position/status

Non-executive director

 

b)

Initial Notification Amendment

Initial Notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

UDG Healthcare plc

 

b)

LEI

549300IWG5ZPP6B8HH13

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary Shares of €0.05 each in UDG Healthcare plc

 

ISIN: IE0033024807

b)

Nature of the transaction  

(i)            Purchase of shares

 

c)

Price(s) and volume(s)

 

Price

Volume

(i)            £7.10 per share

5,000 Ordinary Shares

 

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

2019-05-28

 

 

f)

Place of the transaction

United Kingdom

 

 

 

g)

Additional Information

 

 

 

 

 

For further information, please contact:

 

Damien Moynagh

General Counsel & Company Secretary

Tel: +353-1-4689000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFIFEIIIVIA

Last news